Reversal of chemo-resistance by DSF through the inhibition of NF-κB was also observed in breast cancer cells and human glioblastoma cell lines (Yip et al., 2011; Liu et al., 2012; Liu et al., 2014). Here, NFKB1 is linked to breast cancer.